Skip to main content

OKYO Pharma Ltd

corporate_fare Company Profile

OKYO Pharma Ltd

OKYO·NASDAQ·Healthcare·CIK 0001849296

OKYO Pharma Limited is a clinical-stage biopharmaceutical company focused on developing advanced treatments for patients with inflammatory eye diseases and ocular pain. The company was originally incorporated in the British Virgin Islands as Jellon Enterprises, Inc. on July 4, 2007. Its name changed several times, becoming Minor Metals & Mining, Inc. on October 24, 2007, Emerging Metals Limited on November 28, 2007, West African Minerals Corporation on December 9, 2011, and OKYO Pharma Corporation on January 10, 2018. On July 3, 2018, following shareholder approval to cancel its AIM listing and migrate to Guernsey, the company was registered under the Guernsey Companies Law as OKYO Pharma Limited, with company number 65220. Its Ordinary Shares were listed on the standard segment of the Official List of the FCA and traded on the Main Market of the London Stock Exchange from July 17, 2018, until May 22, 2023. Since May 22, 2023, the NASDAQ Capital Market has been the principal trading market for its ordinary shares. The company is domiciled in Guernsey, with its registered office at Martello Court, Admiral Park, St. Peter Port, Guernsey GY1 3HB.

OKYO Pharma Ltd (NASDAQ:OKYO) is a publicly traded company in the Healthcare sector. Wiseek monitors OKYO SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • OKYO Pharma Expands Scientific Advisory Board with Key Ophthalmology Expert
  • OKYO Pharma to Present Positive Phase 2 Urcosimod Data for Neuropathic Corneal Pain at Major Scientific Conferences
  • OKYO Pharma Advances Lead Candidate Urcosimod with Positive Phase 2 Data and Pivotal Trial Plans
  • Urcosimod Phase 2a Trial Shows Meaningful QoL Improvements in Neuropathic Corneal Pain
  • OKYO Pharma Secures Additional $2.05M from Over-Allotment, Bringing Total Offering Proceeds to $22M

Financial Snapshot

Fiscal year ended March 31, 2025
Net Income
-$4.71M
Diluted EPS
-$0.20
Op. Cash Flow
-$1.81M
Free Cash Flow
-$1.81M
Cash & Equivalents
$1.56M
Debt / Equity
0.00×
Source: 20-F · filed 2025-08-12 · accession 0001641172-25-023204

Insider Transactions

OKYO files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with O →
$1.52
52-week range · as of 2026-05-19 $1.38 – $3.35
Market cap
$78.08M
Volume
157.2K (2.9× avg)
3-mo avg 54.6K
Live data · 2026-06-14 03:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed OKYO - Latest Insights

OKYO
May 19, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.62
Real-time Price: $1.52 info
Change: -$0.100 (-6%) info
Market Cap: $78.083M info
OKYO
Apr 29, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.57
Real-time Price: $1.52 info
Change: -$0.050 (-3%) info
Market Cap: $78.083M info
OKYO
Apr 07, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.58
Real-time Price: $1.52 info
Change: -$0.061 (-4%) info
Market Cap: $78.083M info
OKYO
Mar 18, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.60
Real-time Price: $1.52 info
Change: -$0.080 (-5%) info
Market Cap: $78.083M info
OKYO
Mar 12, 2026, 4:18 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.70
Real-time Price: $1.52 info
Change: -$0.180 (-11%) info
Market Cap: $78.083M info
OKYO
Feb 23, 2026, 11:00 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.74
Real-time Price: $1.52 info
Change: -$0.220 (-13%) info
Market Cap: $78.083M info
OKYO
Feb 17, 2026, 8:23 AM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.61
Real-time Price: $1.52 info
Change: -$0.090 (-6%) info
Market Cap: $78.083M info
OKYO
Feb 13, 2026, 6:06 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.95
Real-time Price: $1.52 info
Change: -$0.430 (-22%) info
Market Cap: $78.083M info
OKYO
Feb 12, 2026, 4:14 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.92
Real-time Price: $1.52 info
Change: -$0.4001 (-21%) info
Market Cap: $78.083M info
OKYO
Feb 10, 2026, 8:26 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.06
Real-time Price: $1.52 info
Change: -$0.540 (-26%) info
Market Cap: $78.083M info
OKYO
Feb 10, 2026, 8:24 PM EST
Filing Type: 424B5
Importance Score:
9
Price at Filing: $2.06
Real-time Price: $1.52 info
Change: -$0.540 (-26%) info
Market Cap: $78.083M info
OKYO
Feb 10, 2026, 8:00 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.14
Real-time Price: $1.52 info
Change: -$0.620 (-29%) info
Market Cap: $78.083M info
OKYO
Feb 02, 2026, 5:22 PM EST
Filing Type: F-3
Importance Score:
9
Price at Filing: $2.12
Real-time Price: $1.52 info
Change: -$0.5998 (-28%) info
Market Cap: $78.083M info
OKYO
Jan 30, 2026, 5:15 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $2.05
Real-time Price: $1.52 info
Change: -$0.530 (-26%) info
Market Cap: $78.083M info
OKYO
Jan 30, 2026, 11:30 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.07
Real-time Price: $1.52 info
Change: -$0.5453 (-26%) info
Market Cap: $78.083M info
OKYO
Jan 28, 2026, 7:40 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.11
Real-time Price: $1.52 info
Change: -$0.590 (-28%) info
Market Cap: $78.083M info
OKYO
Jan 23, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.47
Real-time Price: $1.52 info
Change: -$0.950 (-38%) info
Market Cap: $78.083M info
OKYO
Jan 05, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $2.23
Real-time Price: $1.52 info
Change: -$0.710 (-32%) info
Market Cap: $78.083M info